Cancer imaging and therapy with metal nanoparticles.
Nanotechnology offers unique opportunities for cancer detection, therapy and the ability to monitor therapeutic interventions. This potential has to be analyzed in context of challenges that need to be overcome in translation of nanoparticles to clinical applications including specific delivery in tissues and clearance from the body. Here, we will present a case study of plasmonic nanoparticles in cancer imaging and therapy.
Sokolov
Konstantin
K
Department of Imaging Physics, The UT M.D. Anderson Cancer Center, Houston, TX 77030, USA. kostia@mail.utexas.edu
Tam
Jasmine
J
Tam
Justina
J
Travis
Kort
K
Larson
Tim
T
Aaron
Jesse
J
Harrison
Nathan
N
Emelianov
Stanislav
S
Johnston
Keith
K
D003287:Contrast Media; D066246:ErbB Receptors / Q000032:analysis; D006801:Humans; D007287:Inorganic Chemicals / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D020782:Matrix Metalloproteinases / Q000032:analysis; D053768:Metal Nanoparticles / Q000627:therapeutic use*; D036103:Nanotechnology; D009369:Neoplasms / Q000175:diagnosis* / Q000201:enzymology / Q000628:therapy*; D020349:Surface Plasmon Resonance
D003287:Contrast Media; D007287:Inorganic Chemicals; D066246:ErbB Receptors; D020782:Matrix Metalloproteinases